New Drug May Slow Progression of Parkinson’s Disease

Published on August 1, 2017

A new drug known as D-512 is being developed at New York’s Binghamton University to treat Parkinson’s disease. It promises to limit the progression of Parkinson’s disease while also relieving symptoms more effectively than drugs currently available.About 60,000 Americans…

Read Full Article (External Site)